Although previous results support the high specificity and the great potentiality of serum DKK-1 as a biomarker for detection of myeloma/lung and esophageal carcinomas at an early stage and for monitoring of the relapse of the disease [17,19]. Here, DKK1 is linked to carcinoma of esophagus.